Discontinuation report HUMULIN 30/70 (INSULIN HUMAN BIOSYNTH INJ)
| Report ID | 257310 |
| Drug Identification Number | 00795879 |
| Brand name | HUMULIN 30/70 (INSULIN HUMAN BIOSYNTH INJ) |
| Common or Proper name | 30% insulin injection, 70% insulin isophane, human biosynthetic (rDNA origin) |
| Company Name | ELI LILLY CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | INSULIN ISOPHANE INSULIN |
| Strength(s) | 70UNIT 30UNIT |
| Dosage form(s) | SUSPENSION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | Vial HI0710, 10 mL, 100 units/mL |
| ATC code | A10AD |
| ATC description | INSULINS AND ANALOGUES |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2026-04-30 |
| Actual discontinuation date | |
| Remaining supply date | 2026-04-30 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | The 10 mL vial presentation (Vial HI0710, 10 mL, 100 units/mL) is being discontinued, anticipated remaining supply date may be impacted based on any changes in demand. The following presentation remains available: Humulin 30/70 3.0 mL, 100 units /mL, 5 cartridges/box HI0719 (DIN 01959212) |
| Company comments | For any questions, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays). |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | EXCHANGE TOWER, 130 KING STREET WEST TORONTO, ONTARIO CANADA M5X 1B1 |
| Company contact information | Lilly Canada’s Customer Response Centre 1-888-545-5972. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-05-14 | French | Compare |
| v1 | 2025-05-14 | English | Compare |
Showing 1 to 2 of 2